Skin elasticity improvements, continued texture refinement, and ongoing tissue repair benefits
The Danville man was pre-diabetic and had high blood pressure and cholesterol when he and his doctor decided to try Zepbound, which is similar to ozempic and is approved for weight loss
full long-term data still emerging Not yet approved Pros and cons summarise available published data from peer-reviewed studies
Even here, CagriSema delivered 13.7% mean weight reduction at 68 weeks compared to 3.4% with placebo
NSL literature pointer PMID 1451645 L-Carnitine laboratory index [PMID: 1451645] National Science Labs indexing note for PMID 1451645: review the PubMed methods, models, and limitations before citing
doi: 10.1080/21688370.2023.2292461, 125 RichardJ